Nike’s new ‘Mind’ shoes, launched in January 2026, have generated worldwide excitement for their claim to influence mental well-being. The sportswear giant describes the product as its first neuroscience-based footwear, designed not for exercise but for pre- and post-activity relaxation. Available in mule and sneaker styles priced at $95 and $145 respectively, the shoes reportedly sold out quickly, with over two million people signing up for restock notifications. On resale platforms like StockX, the ‘Light Smoke Grey’ mule version has become Nike’s top-listed shoe since 2016.

According to Nike’s Sport Research Lab, the shoes feature 22 foam nodes that stimulate foot nerves, increasing electrical activity in the brain’s sensorimotor network while calming the default mode network associated with wandering thoughts. The company claims this creates a state of “relaxed alertness.” However, no peer-reviewed studies have yet verified these findings.

Loughborough University’s Dr. Ishara Dharmasena considers the concept scientifically plausible, comparing it to traditional Ayurvedic foot massage. He cautions that prolonged use might reduce effectiveness as the brain adapts, classifying the product as a “passive neuro-wearable” that promotes calm without tracking data.